These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34015037)

  • 1. Comparison of different preparation techniques of dried blood spot quality controls in newborn screening for congenital adrenal hyperplasia.
    Grecsó N; Zádori A; Baráth Á; Galla Z; Rácz G; Bereczki C; Monostori P
    PLoS One; 2021; 16(5):e0252091. PubMed ID: 34015037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
    Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
    Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Confirmation and Differential Diagnosis of Congenital Adrenal Hyperplasia from Dried Blood Spots: Application of a Second-Tier LC-MS/MS Assay in a Cross-Border Cooperation for Newborn Screening.
    Monostori P; Szabó P; Marginean O; Bereczki C; Karg E
    Horm Res Paediatr; 2015; 84(5):311-8. PubMed ID: 26397944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of a candidate reference measurement procedure for detecting 17α-hydroxyprogesterone in dried blood spots using isotope dilution liquid chromatography tandem mass spectrometry.
    He Z; Dai H; Shen J; Huang Y; Liu J; Yan R; Zhang F; Yan S
    Anal Bioanal Chem; 2024 Aug; 416(20):4635-4645. PubMed ID: 38949681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
    Magnisali P; Chalioti MB; Livadara T; Mataragas M; Paliatsiou S; Malamitsi-Puchner A; Moutsatsou P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1565-72. PubMed ID: 21514253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancement in steroid hormone analysis by LC-MS/MS in clinical routine diagnostics - A three year recap from serum cortisol to dried blood 17α-hydroxyprogesterone.
    Gaudl A; Kratzsch J; Ceglarek U
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105389. PubMed ID: 31158444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal screening: identification of children with 11β-hydroxylase deficiency by second-tier testing.
    Janzen N; Riepe FG; Peter M; Sander S; Steuerwald U; Korsch E; Krull F; Müller HL; Heger S; Brack C; Sander J
    Horm Res Paediatr; 2012; 77(3):195-9. PubMed ID: 22508345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of a steroid profile in heel prick blood using LC-MS/MS.
    Boelen A; Ruiter AF; Claahsen-van der Grinten HL; Endert E; Ackermans MT
    Bioanalysis; 2016; 8(5):375-84. PubMed ID: 26891684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
    De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
    Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid steroid hormone quantification for congenital adrenal hyperplasia (CAH) in dried blood spots using UPLC liquid chromatography-tandem mass spectrometry.
    Janzen N; Sander S; Terhardt M; Steuerwald U; Peter M; Das AM; Sander J
    Steroids; 2011 Dec; 76(13):1437-42. PubMed ID: 21839763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
    Watanabe K; Tsuji-Hosokawa A; Hashimoto A; Konishi K; Ishige N; Yajima H; Sutani A; Nakatani H; Gau M; Takasawa K; Tajima T; Hasegawa T; Morio T; Kashimada K
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3341-3352. PubMed ID: 36071550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia.
    Minutti CZ; Lacey JM; Magera MJ; Hahn SH; McCann M; Schulze A; Cheillan D; Dorche C; Chace DH; Lymp JF; Zimmerman D; Rinaldo P; Matern D
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3687-93. PubMed ID: 15292289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.
    Stroek K; Ruiter A; van der Linde A; Ackermans M; Bouva MJ; Engel H; Jakobs B; Kemper EA; van den Akker ELT; van Albada ME; Bocca G; Finken MJJ; Hannema SE; Mieke Houdijk ECA; van der Kamp HJ; van Tellingen V; Paul van Trotsenburg AS; Zwaveling-Soonawala N; Bosch AM; de Jonge R; Heijboer AC; Claahsen-van der Grinten HL; Boelen A
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4487-e4496. PubMed ID: 34171085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Storage stability of five steroids and in dried blood spots for newborn screening and retrospective diagnosis of congenital adrenal hyperplasia.
    Grecsó N; Zádori A; Szécsi I; Baráth Á; Galla Z; Bereczki C; Monostori P
    PLoS One; 2020; 15(5):e0233724. PubMed ID: 32470014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J; Barat P; Fagour L; Corcuff JB
    Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract]   [Full Text] [Related]  

  • 19. Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38,935 Infants.
    Güran T; Tezel B; Gürbüz F; Selver Eklioğlu B; Hatipoğlu N; Kara C; Şimşek E; Çizmecioğlu FM; Ozon A; Baş F; Aydın M; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):13-23. PubMed ID: 30111524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid profiling for the diagnosis of congenital adrenal hyperplasia by microbore ultra-performance liquid chromatography-tandem mass spectrometry.
    Feng D; Wang Z; Li H; Shi X; Zou L; Kong H; Xu Z; Yu C; Hu C; Xu G
    Clin Chim Acta; 2023 Mar; 543():117304. PubMed ID: 36958425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.